Hactosec

Active substance : levodropropizine

Form : Syrup

Dosage : Each ml of syrup contains 6 mg of levodropropizine (30 mg/5ml)

Packaging :

Cardboard box including 150 ml of syrup in a  glass bottle closed and a plastic dosing device.

Target :

Children as from 2 years of age up to adults

Hactosec is indicated  for the Symptomatic treatment of dry cough (non-productive, disturbing cough).

Adults and children from 12 years and older

• Maximum 60 mg levodroprozine (10 ml syrup), three times daily. The time between administrations should be at least 6 hours.

Pediatric population

Children 6 to 12 years

• 12 mg to maximum 30 mg levodropropizine (2 ml to maximum 5 ml syrup) three times daily. The time between administrations should be at least 6 hours.

Children 2 to 6 years

• 12 mg to 18 mg levodropropizine (2 ml to 3 ml syrup), maximum three times daily. The time between administrations should be at least 6 hours.

The usual dose is 1 mg to 2 mg per kg of bodyweight (eq. with 0.15 ml to 0.3 ml of syrup).